The Upper Peninsula Health Plan (UPHP) covered drugs are selected by the plan with the help of a team of doctors and pharmacists. The drug list (Formulary) must meet requirements set by Medicare. Medicare has approved the UPHP formularies.
UPHP covers both brand-name drugs and generic drugs. Generic drugs have the same active-ingredient formula as a brand-name drugs and are rated by the U.S. Food and Drug Administration to be as safe and effective as the brand-name drugs, while also costing less.
The UPHP Drug List may change throughout the year. Please see the “Formulary Change History” for your health plan below for further information or contact the plan for the most recent list of drugs.
Information on prior authorization, step therapy, formulary change history, quantity limits, out-of-network coverage, formulary exceptions and coverage determinations, and formulary appeals and grievances is below. (Please note: clicking some of these links will take you away from UPHP’s website).
Certain drugs may need to get approval from UPHP before we will agree to cover the drug for a member. This is called “prior authorization.” Sometimes plan approval is required so that we can be sure the drug is covered by Medicare rules. Sometimes the requirement for getting approval in advance helps guide appropriate use of certain drugs. If the prior authorization does not get approved, the drug might not be covered by the health plan. Refer to the UPHP Evidence of Coverage for further information on prior authorizations, or call UPHP Customer Service at 1-877-349-9324 (TTY: 711), Monday through Friday from 8 a.m. to 9 p.m. Eastern time, with weekend hours Oct. 1 through March 31. The call is free. For more information on prior authorization, view the documents below.
Step therapy encourages members to try a safer or more effective drug before the plan covers another drug. For example, if Drug A and Drug B treat the same medical condition, UPHP may require members to try Drug A first. If Drug A does not work, the health plan will then cover Drug B. This requirement to try a different drug first is called “step therapy.”
Refer to the UPHP Evidence of Coverage for further information on step therapy, or call Magellan Rx Customer Service at 1-844-827-0182 (TTY: 711), seven days per week, 24 hours per day. The call is free. For more information on step therapy, view the documents below.
Emergent and urgently needed out-of-network care are covered. If members must use an out-of-network pharmacy, they will generally have to pay the full cost (rather than paying their normal share of the cost) when they fill the prescription. Members can ask UPHP to reimburse them for our share of the cost. Refer to the UPHP Evidence of Coverage for further information on out-of-network coverage and asking the health plan to reimburse members for their share of the cost, or call Magellan Rx’s Customer Service at 1-844-827-0182 (TTY: 711) 24 hours a day, seven days a week. The call is free.
If a drug is not covered in the way you would like it to be covered, you can ask the plan to make an “exception” by submitting a formulary exception form. An exception is a type of coverage decision. Similar to other types of coverage decisions, if we turn down your request for an exception, you can appeal our decision. Download and print both the Centers for Medicare and Medicaid Services (CMS) Coverage Determination Request Form and appropriate UPHP Medicare Part D Coverage Determination Request Form below.
- CMS Coverage Determination Request Form
- UPHP Advantage & UPHP Choice Part D Coverage Determination Request Form
- UPHP MI Health Link Part D Coverage Determination Request Form
Providers may submit either form via fax to Magellan Rx at 1-248-341-8133 or via mail to:
Magellan Rx Management
PO Box 2187
Maryland Heights, MO 63043
Read more about the Medicare Prescription Drug Coverage Determination and Exceptions process.
For information on the CMS Best Available Evidence policy, click here.
(Clicking on this link will take you away from UPHP’s website.)
Page Last Updated: 12/3/2019